Mo1561 GUT SELECTIVE BIOLOGIC, VEDOLIZUMAB, IS ASSOCIATED WITH LOWER RATES OF LIVER RELATED COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH CIRRHOSIS-A NATIONWIDE ANALYSIS

Abstract

Peer reviewed

Rama Nanah, M Housam Nanah, Robana Nanah, Osama Hamid and Jamak Modaresi Esfeh

Gastroenterology (New York, N.Y. 1943), Vol.166(5 Suppl), pp.S-1693-S-1693

05/18/2024

DOI: 10.1016/S0016-5085(24)04355-5

View Online

Title: Subtitle: Mo1561 GUT SELECTIVE BIOLOGIC, VEDOLIZUMAB, IS ASSOCIATED WITH LOWER RATES OF LIVER RELATED COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH CIRRHOSIS-A NATIONWIDE ANALYSIS
Creators: Rama Nanah
M Housam Nanah
Robana Nanah
Osama Hamid
Jamak Modaresi Esfeh
Resource Type: Abstract
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.166(5 Suppl), pp.S-1693-S-1693
DOI: 10.1016/S0016-5085(24)04355-5
ISSN: 0016-5085
Language: English
Date published: 05/18/2024
Academic Unit: Internal Medicine
Record Identifier: 9985179090602771

1 Record Views